Hip FracturesSWalker-VRNCT06025981
Clinical Study of the Effects of a SWalker II and VR for Hip Fracture Rehabilitation in the Elderly
A study testing Preliminary Phase, Phase I - Early gait rehabilitation and Phase II - Maintenance gait function ( with VR) in people with Hip Fractures and Gait Disorders in Old Age, run by Werium Assistive Solutions at 2 sites in Spain.
Trial summary
This project is structured in two distinct phases. The first phase deals with the recovery of the hip fracture in the acute phase up to ambulation, and the second is understood as the continuation of functional improvement of gait. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Hip Fractures, Gait Disorders in Old Age
- What is being tested?
- Preliminary Phase, Phase I - Early gait rehabilitation and Phase II - Maintenance gait function ( with VR)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 2 sitesSpain
- Study dates
- 10 Jan 2023to 30 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Participants of both sexes over 65 years of age,
- Patients with a height of less than 180 cm,
- Patients weighing less than 90 kg,
- Patients who have suffered a hip fracture* and wish to participate in the study.
- In addition, they must sign and understand the informed consent form.
Who cannot join
- Cognitive status insufficient to understand and execute instructions given by the physiotherapist.
- Patients needing rehabilitation after hip fracture may vary from a few days to a few weeks after the period of occurrence of the hip fracture, depending on the complications that could arise and the type of surgery used, with a pre-set limit of one month.
Trial locations and contacts
2 sites in 1 country.
Spain2 sites
Werium Assistive Solutions
Arganda, Madrid, 28500
Albertia Servicios Sociosanitarios
Madrid, 28222
About this study
Official title: Clinical Study of the Effects of a Robotic Walker and Immersive Technology for Hip Fracture Rehabilitation in the Elderly
This project is structured in two distinct phases. The first phase deals with the recovery of the hip fracture in the acute phase up to ambulation, and the second is understood as the continuation of functional improvement of gait. In the first phase, the aim is to evaluate the effects of the use of the robotic device (SWalker) on the physical improvement of the patient. While in the second phase, the objective is to evaluate the effects of virtual reality technology combined with the use of the SWalker.Therefore, the following specific objectives are identified:
- Phase I: To analyze the effects of SWalker application in patients with acute hip fracture on clinical parameters of rehabilitation.
- Phase II: To study the effects of the application of the SWalker combined with immersive technology in people with impaired gait function after hip fracture.
Read the detailed description
In the preliminary phase, the usability and acceptance of the SWalker II system combined with virtual reality is evaluated with a group of healthy subjects. For this purpose, an exposure session and the evaluation of the system based on questionnaires are carried out. On the other hand, a gait characterization session (capture of ROM and EMG) is performed inside and outside the walker with different speeds and weight loads.
In the first phase of the clinical study, patients with hip fractures in the early rehabilitation phase were recruited. They are randomly assigned to a control group or experiment group. And for a period of 6 weeks, both groups carry out the same rehabilitation exercise program based on strength, balance and ambulation exercise. The difference is that the experimental group performs the rehabilitation exercises with the SWalker, and the control group performs these exercises with conventional parallel bars.
In the second phase of the clinical study, these same patients who have passed the first pass, move on to a 6-weeks program of maintenance and improvement of gait function. Again, they are divided into 2 groups, control and experimental. So the control group will perform walking exercises with the Swalker and conventional balance exercises and the experimental group will perform walking and balance exercises with SWalker and virtual reality.
- Conditions
- Hip Fractures, Gait Disorders in Old Age
- Being tested
- Preliminary Phase, Phase I - Early gait rehabilitation, Phase II - Maintenance gait function ( with VR)
- Medical subject headings
- Hip Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Preliminary PhaseOther
In the preliminary phase, the characterization of the functionality of the SWalker robotic system, as well as the functionality of the Virtual Reality system, will be carried out. All descriptive usability questionnaires completed by the participants and electro-biomechanical parameters will be collected using the robot's measurement systems to analyze the functionality.
Phase I - Early gait rehabilitationOther
In the first phase, the participants will carry out the rehabilitation program for hip fracture in acute phase that will last 6 weeks. Participants will be randomized between control and experimental groups. In which the therapeutic intervention is based on the usual rehabilitation guidelines that integrate exercises aimed at improving strength, gait, functional mobility and balance. In the case of the experimental group, a robotic walker will be used to practice walking.
Phase II - Maintenance gait function ( with VR)Other
In the second phase, participants will carry out a 6-week program to consolidate walking function. Participants will be randomized between control and experimental groups. In which the therapeutic intervention is based on the use of the robotic system for gait exercise. In the case of the experimental group, the use of virtual reality will also be integrated.
| Study group | Role | What they receive |
|---|---|---|
| Preliminary Phase | Other | 20 healthy subjects will perform an experimental session for characterization of functional status with clinical scales; characterization of gait with SWalker using ROM and EMG at different speeds and weight bearing; and assessment of system usability with VR using standardized questionnaires. Receives: Other: Preliminary Phase |
| Phase I and II | Other | In both phases 100 subjects will perform a gait rehabilitation intervention program (phase 1) and maintenance (phase 2), in which they will employ the use of the robotic walker and virtual reality depending on the group and phase. The evolution of functional clinical parameters will be studied for both groups and phases. Receives: Other: Phase I - Early gait rehabilitation; Other: Phase II - Maintenance gait function ( with VR) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Pain
The evolution of the functional clinical scales will be studied (pain): Pain by means of the Verbal Rating Scale, a five-point scale and consists of a list of adjectives describing various levels of symptom intensity (0= no itch, 1= mild itch, 2= moderate itch , 3= severe itch and 4=very severe itch).
Measured: 6 weeks
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Autonomy/independence. Ambulation
The evolution of the functional clinical scales will be studied (autonomy/independence): Functional limitation in early post-acute phase by means of Cumulative Ambulation Score (CAS) (Physical test). The CAS describes the patient's independence with regard to three activities (getting in and out of bed, sit-to-stand-to-sit from a chair, and walking). Each activity is assessed on a three-point ordinal scale from 0-2 (0 = Not able to, despite human assistance and verbal cueing, 1 = Able to, with human assistance and/or verbal cueing from one or more persons, 2 = Able to safely, without human assistance or verbal cueing, use of a walking aid allowed) resulting in a total daily CAS score ranging from 0 to 6.
Measured: 6 weeks
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Strength
The evolution of the functional clinical scales will be studied (strength): Muscle strength of the lower limbs through quadriceps extension test or lower limb dynamometer (physiological parameter).
Measured: 6 weeks
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Gait
The evolution of the functional clinical scales will be studied (gait and balance): Gait speed using the 10 metre Walk Test (10MWT) (physical test), provided the patient can walk without human assistance; The 10 Metre Walk Test is a performance measure used to assess walking speed in meters per second over a short distance. The total time is recorded in m/s. Household Ambulator <0.40 m/s; Limited Community Ambulator 0.40 to <0.80 m/s; Community Ambulator ≥0.80 m/s.
Measured: 6 weeks
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Autonomy/independence. Fear of falling
The evolution of the functional clinical scales will be studied (autonomy/independence): Fear of falling by means of the Falls Efficacy Scale International (questionnaire); The total score ranges from 16 to 64, where 16 indicates "no concern" and 64 indicates "extremely concerned about falling" during the performance of the specific activities suggested by the questionnaire.
Measured: 6 weeks
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Autonomy/independence. Quality of life.
The evolution of the functional clinical scales will be studied (autonomy/independence): Quality of life through the 36-Item Short Form Survey (SF-36) (questionnaire). The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
Measured: 6 weeks
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Autonomy/independence. Mobility
The evolution of the functional clinical scales will be studied (autonomy/independence): Mobility using the New Mobility Test (Physical test), also known as Parker Mobility Test. It is a composite score of the patient's ability to perform: indoor walking, outdoor walking, and shopping, providing a score between 0 and 3 (0 - not at all, 1 - with help from another person, 2 - with an aid, 3 - no difficulty) for each function, resulting in a total score from 0 (no walking ability at all) to 9 (fully independent) .
Measured: 6 weeks
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Gait and Balance
The evolution of the functional clinical scales will be studied (gait and balance): Functionality through the Timed Up \& Go test (physical test). Its score is the time spent (seconds) while the subject is standing from an armchair, walking 3 meters, returning to the chair walking 3 additional meters and sitting down. It is considered that scores of 10 seconds or less indicate normal mobility, 11-20 seconds are within normal limits for frail elderly and disabled patients, and greater than 20 seconds means the person needs assistance.
Measured: 6 weeks
Secondary outcomes (8)
Usability of virtual reality system combined with the robotic system (SWalker) - Presence
Descriptive analysis of system's usability: questionnaires will be collected to assess the following aspects: feeling of presence in the virtual environment using the Presence Questionnaire, PQ); Presence Questionnaire consists of 32 questions each on a 1 to 7 scale. The final presence score is the sum of 32 such questions. A total score < 4 is considered unsatisfactory, and score >4 is considered satisfactory.
Measured: 1 week
Usability of virtual reality system combined with the robotic system (SWalker) - Safety
Descriptive analysis of system's safety: the Simulator Sickness Questionnaire, SSQ, will be collected to assess the presence of adverse effects due to cybersickness. Each item is rated with the scale from none (0), slight (1), moderate (2) to severe (3). Through some calculations, four representative scores can be found. Nausea-related subscore (N), Oculomotorrelated subscore (O), Disorientation-related subscore (D) are the scores for the symptoms for the specific aspects. Total Score (TS) is the score representing the overall severity of cybersickness experienced by the users of virtual reality systems. It is suggested that total scores can be associated with negligible (< 5), minimal (5 - 10), significant (10 - 15), and concerning (15 - 20) symptoms. A simulator resulting in total scores above 20 is considered "bad".
Measured: 1 week
Feasibility of robotic system (SWalker) - Gait
Gait and balance using the SWalker will be studied in a 4-meter walk at 3 different speeds for 0%, 25% and 50% of weight bearing: Timed Up \& Go test (physical test). Its score is the time spent (seconds) while the subject is standing from an armchair, walking 3 meters, returning to the chair walking 3 additional meters and sitting down. It is considered that scores of 10 seconds or less indicate normal mobility, 11-20 seconds are within normal limits for frail elderly and disabled patients, and greater than 20 seconds means the person needs assistance.
Measured: 1 week
Feasibility of robotic system (SWalker) - Hip ROM
Hip range of motion (ROM) (physiological parameter) will be studied (using the SWalker) in a 4-meter walk at 3 different speeds for 0%, 25% and 50% of weight bearing. In general, the average range of motion for hip extension in a healthy person is about 20-30 degrees out of a neutral stance.
Measured: 1 week
Usability of virtual reality system combined with the robotic system (SWalker) - Usability
Descriptive analysis of system's usability: questionnaires will be collected to assess the following aspects: general usability of the system using the System Usability Scale (questionnaire) and the Post-Study System Usability Questionnaire. The System Usability Scale score ranges from 0 to 100, being a total score above 80.3 considered excellent, a score between 68 - 80.3 is considered good, and below 68 is considered poor. The Post-Study System Usability Questionnaire score starts with 1 (strongly agree) and ends with 7 (strongly disagree). The lower the score, the better the performance and satisfaction, considering 4 neutral score.
Measured: 1 week
Feasibility of robotic system (SWalker) - Gait and Balance
Gait and balance using the SWalker will be studied in a 4-meter walk at 3 different speeds for 0%, 25% and 50% of weight bearing: the 10-meter walking speed (10MWT) (physical test). The 10 Metre Walk Test is a performance measure used to assess walking speed in meters per second over a short distance. The total time is recorded in m/s. Household Ambulator <0.40 m/s; Limited Community Ambulator 0.40 to <0.80 m/s; Community Ambulator ≥0.80 m/s.
Measured: 1 week
Feasibility of robotic system (SWalker) - Physical Performance
Gait and balance using the SWalker will be studied in a 4-meter walk at 3 different speeds for 0%, 25% and 50% of weight bearing: the Short Physical Performance Battery test (SPPB) (physical test). SPPB scores range from zero to 12 possible points. SPPB score of 3-9 points in persons with possible sarcopenia but no mobility disability indicates frailty; SPPB score of 10 or greater for persons with no sarcopenia and no mobility disability indicates robustness. Persons with a score of 2 or lower who have sarcopenia, and mobility disability are determined to be disabled.
Measured: 1 week
Feasibility of robotic system (SWalker) - EMG activity
The electromyographic (EMG) activity of the two leg muscles (Tibialis anterior [TA] and Soleus [SOL]) (physiological parameter) will be studied (using the SWalker) in a 4-meter walk at 3 different speeds for 0%, 25% and 50% of weight bearing. It will be studied the peak amplitudes (mV) for left and right leg muscles s-EMG activity.
Measured: 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Sep 2023
- Study start10 Jan 2023
- Primary completion30 Jan 2023
- Study completion30 Dec 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Hip FracturesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- The model is that of a prospective, longitudinal, multicenter, randomized controlled trial (RCT), open-label and analytical: * RCT: A rehabilitation intervention with SWalker (experimental group) and a conventional one (control group) will be implemented, following randomization. * Prospective longitudinal: Study requiring follow-up of patients during the hip fracture rehabilitation period. * Open multicenter: Inclusion is not limited to any individual who meet the inclusion criteria from Valle de la Oliva-Majadahonda, Ciempozuelos, Mirasierra and Moratalaz nursing homes. * Analytical: Results are presented in a descriptive way and entering into the analytical statistics of comparison and relationship. analytical comparison and relationship.
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Werium Assistive Solutions
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06025981
- Sponsor's protocol ID
- SWalker-II-VR
- Acronym
- SWalker-VR
- Status last verified
- Jul 2023
- First submitted
- 20 Jun 2023
- Last updated
- 6 Sep 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Costa V, Rojo A, Lopez-Lopez S, Pareja-Galeano H, Velasquez A, Perea L, Raya R. Evaluating the Usability and Safety of Virtual Reality Application Combined with the SWalker for Functional Gait Rehabilitation. Games Health J. 2024 Oct;13(5):397-405. doi: 10.1089/g4h.2023.0172. Epub 2024 May 17.
PubMed 38757664
Study at a glance
From the registry record, last updated by the sponsor on 6 Sep 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Study of the Effects of a Robotic Walker and Immersive Technology for Hip Fracture Rehabilitation in the Elderly
- ClinicalTrials.gov ID
- NCT06025981
- Acronym / sponsor ID
- SWalker-VR / SWalker-II-VR
- Conditions
- Hip Fractures, Gait Disorders in Old Age
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Werium Assistive SolutionsIndustry (pharma, biotech, devices)
- Study start
- 10 Jan 2023 (actual)
- Primary completion
- 30 Jan 2023 (actual)
- Study completion
- 30 Dec 2023 (estimated)
- First posted
- 6 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project is structured in two distinct phases. The first phase deals with the recovery of the hip fracture in the acute phase up to ambulation, and the second is understood as the continuation of functional improvement of gait. In the first phase, the aim is to evaluate the effects of the use of the robotic device (SWalker) on the physical improvement of the patient. While in the second phase, the objective is to evaluate the effects of virtual reality technology combined with the use of the SWalker.Therefore, the following specific objectives are identified:
- Phase I: To analyze the effects of SWalker application in patients with acute hip fracture on clinical parameters of rehabilitation.
- Phase II: To study the effects of the application of the SWalker combined with immersive technology in people with impaired gait function after hip fracture.
Detailed description
In the preliminary phase, the usability and acceptance of the SWalker II system combined with virtual reality is evaluated with a group of healthy subjects. For this purpose, an exposure session and the evaluation of the system based on questionnaires are carried out. On the other hand, a gait characterization session (capture of ROM and EMG) is performed inside and outside the walker with different speeds and weight loads.
In the first phase of the clinical study, patients with hip fractures in the early rehabilitation phase were recruited. They are randomly assigned to a control group or experiment group. And for a period of 6 weeks, both groups carry out the same rehabilitation exercise program based on strength, balance and ambulation exercise. The difference is that the experimental group performs the rehabilitation exercises with the SWalker, and the control group performs these exercises with conventional parallel bars.
In the second phase of the clinical study, these same patients who have passed the first pass, move on to a 6-weeks program of maintenance and improvement of gait function. Again, they are divided into 2 groups, control and experimental. So the control group will perform walking exercises with the Swalker and conventional balance exercises and the experimental group will perform walking and balance exercises with SWalker and virtual reality.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
- Model description
- The model is that of a prospective, longitudinal, multicenter, randomized controlled trial (RCT), open-label and analytical: * RCT: A rehabilitation intervention with SWalker (experimental group) and a conventional one (control group) will be implemented, following randomization. * Prospective longitudinal: Study requiring follow-up of patients during the hip fracture rehabilitation period. * Open multicenter: Inclusion is not limited to any individual who meet the inclusion criteria from Valle de la Oliva-Majadahonda, Ciempozuelos, Mirasierra and Moratalaz nursing homes. * Analytical: Results are presented in a descriptive way and entering into the analytical statistics of comparison and relationship. analytical comparison and relationship.
| Arm | Type | Receives |
|---|---|---|
| Preliminary Phase | Other | Other: Preliminary Phase20 healthy subjects will perform an experimental session for characterization of functional status with clinical scales; characterization of gait with SWalker using ROM and EMG at different speeds and weight bearing; and assessment of system usability with VR using standardized questionnaires. |
| Phase I and II | Other | Other: Phase I - Early gait rehabilitation, Other: Phase II - Maintenance gait function ( with VR)In both phases 100 subjects will perform a gait rehabilitation intervention program (phase 1) and maintenance (phase 2), in which they will employ the use of the robotic walker and virtual reality depending on the group and phase. The evolution of functional clinical parameters will be studied for both groups and phases. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Participants of both sexes over 65 years of age,
- Patients with a height of less than 180 cm,
- Patients weighing less than 90 kg,
- Patients who have suffered a hip fracture* and wish to participate in the study.
- In addition, they must sign and understand the informed consent form.
Key exclusion criteria (2 listed)
- Cognitive status insufficient to understand and execute instructions given by the physiotherapist.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Preliminary PhaseIn the preliminary phase, the characterization of the functionality of the SWalker robotic system, as well as the functionality of the Virtual Reality system, will be carried out. All descriptive usability questionnaires completed by the participants and electro-biomechanical parameters will be collected using the robot's measurement systems to analyze the functionality. | Other | Preliminary Phase |
| Phase I - Early gait rehabilitationIn the first phase, the participants will carry out the rehabilitation program for hip fracture in acute phase that will last 6 weeks. Participants will be randomized between control and experimental groups. In which the therapeutic intervention is based on the usual rehabilitation guidelines that integrate exercises aimed at improving strength, gait, functional mobility and balance. In the case of the experimental group, a robotic walker will be used to practice walking. | Other | Phase I and II |
| Phase II - Maintenance gait function ( with VR)In the second phase, participants will carry out a 6-week program to consolidate walking function. Participants will be randomized between control and experimental groups. In which the therapeutic intervention is based on the use of the robotic system for gait exercise. In the case of the experimental group, the use of virtual reality will also be integrated. | Other | Phase I and II |
Primary outcome
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Pain
Time frame: 6 weeks
The evolution of the functional clinical scales will be studied (pain): Pain by means of the Verbal Rating Scale, a five-point scale and consists of a list of adjectives describing various levels of symptom intensity (0= no itch, 1= mild itch, 2= moderate itch , 3= severe itch and 4=very severe itch).
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Autonomy/independence. Ambulation
Time frame: 6 weeks
The evolution of the functional clinical scales will be studied (autonomy/independence): Functional limitation in early post-acute phase by means of Cumulative Ambulation Score (CAS) (Physical test). The CAS describes the patient's independence with regard to three activities (getting in and out of bed, sit-to-stand-to-sit from a chair, and walking). Each activity is assessed on a three-point ordinal scale from 0-2 (0 = Not able to, despite human assistance and verbal cueing, 1 = Able to, with human assistance and/or verbal cueing from one or more persons, 2 = Able to safely, without human assistance or verbal cueing, use of a walking aid allowed) resulting in a total daily CAS score ranging from 0 to 6.
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Strength
Time frame: 6 weeks
The evolution of the functional clinical scales will be studied (strength): Muscle strength of the lower limbs through quadriceps extension test or lower limb dynamometer (physiological parameter).
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Gait
Time frame: 6 weeks
The evolution of the functional clinical scales will be studied (gait and balance): Gait speed using the 10 metre Walk Test (10MWT) (physical test), provided the patient can walk without human assistance; The 10 Metre Walk Test is a performance measure used to assess walking speed in meters per second over a short distance. The total time is recorded in m/s. Household Ambulator <0.40 m/s; Limited Community Ambulator 0.40 to <0.80 m/s; Community Ambulator ≥0.80 m/s.
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Autonomy/independence. Fear of falling
Time frame: 6 weeks
The evolution of the functional clinical scales will be studied (autonomy/independence): Fear of falling by means of the Falls Efficacy Scale International (questionnaire); The total score ranges from 16 to 64, where 16 indicates "no concern" and 64 indicates "extremely concerned about falling" during the performance of the specific activities suggested by the questionnaire.
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Autonomy/independence. Quality of life.
Time frame: 6 weeks
The evolution of the functional clinical scales will be studied (autonomy/independence): Quality of life through the 36-Item Short Form Survey (SF-36) (questionnaire). The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Autonomy/independence. Mobility
Time frame: 6 weeks
The evolution of the functional clinical scales will be studied (autonomy/independence): Mobility using the New Mobility Test (Physical test), also known as Parker Mobility Test. It is a composite score of the patient's ability to perform: indoor walking, outdoor walking, and shopping, providing a score between 0 and 3 (0 - not at all, 1 - with help from another person, 2 - with an aid, 3 - no difficulty) for each function, resulting in a total score from 0 (no walking ability at all) to 9 (fully independent) .
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Gait and Balance
Time frame: 6 weeks
The evolution of the functional clinical scales will be studied (gait and balance): Functionality through the Timed Up \& Go test (physical test). Its score is the time spent (seconds) while the subject is standing from an armchair, walking 3 meters, returning to the chair walking 3 additional meters and sitting down. It is considered that scores of 10 seconds or less indicate normal mobility, 11-20 seconds are within normal limits for frail elderly and disabled patients, and greater than 20 seconds means the person needs assistance.
8 secondary outcomes
Usability of virtual reality system combined with the robotic system (SWalker) - Presence
Time frame: 1 week
Usability of virtual reality system combined with the robotic system (SWalker) - Safety
Time frame: 1 week
Feasibility of robotic system (SWalker) - Gait
Time frame: 1 week
Feasibility of robotic system (SWalker) - Hip ROM
Time frame: 1 week
Usability of virtual reality system combined with the robotic system (SWalker) - Usability
Time frame: 1 week
Feasibility of robotic system (SWalker) - Gait and Balance
Time frame: 1 week
Feasibility of robotic system (SWalker) - Physical Performance
Time frame: 1 week
Feasibility of robotic system (SWalker) - EMG activity
Time frame: 1 week
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Sep 2023.
- Derived from this study: PubMed 38757664Costa V, Rojo A, Lopez-Lopez S, Pareja-Galeano H, Velasquez A, Perea L, Raya R. Evaluating the Usability and Safety of Virtual Reality Application Combined with the SWalker for Functional Gait Rehabilitation. Games Health J. 2024 Oct;13(5):397-405. doi: 10.1089/g4h.2023.0172. Epub 2024 May 17.
- Individual participant dataSharing planned: No
Related trials for Hip Fractures
Not yet recruiting
Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery
Femur Neck Fracture, Hip Fractures
RecruitingObservational study
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
Fracture; Pelvic, Insufficiency Fractures
Not yet recruiting
A Decision Support Tool for Common Surgical Fixations of Hip Fractures
Hip Fracture Surgeries, High Risk Population of Hip Fractures
Enrolling by invitationObservational study
GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)
Osteoporosis
Recruiting
Monitored Anesthesia Care and Soft Tissue Infiltration With Local Anesthesia Feasibility Trial
Hip Fracture Surgeries, Intertrochanteric Fracture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Preliminary Phase, Phase I - Early gait rehabilitation and Phase II - Maintenance gait function ( with VR) in people with Hip Fractures and Gait Disorders in Old Age, run by Werium Assistive Solutions at 2 sites in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Effects of robotic system (SWalker + VR) use in gait rehabilitation - Pain (time frame: 6 weeks). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06025981, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2023.